Toxoplasma gondii infection in the peritoneal macrophages of rats treated with glucocorticoids

Parasitology Research

Volumn 113, Issue 1, 2014, Pages 351-358

  Wang, Tao ^a,e   Gao, Jiang Mei ^a   Yi, Si Qi ^a   Geng, Guo Qing ^a   Gao, Xiao Jie ^a   Shen, Ji Long ^b   Lu, Fang Li ^c   Wen, Yan Zi ^a   Hide, Geoff ^d   Lun, Zhao Rong ^a,d  

^a SUN YAT SEN UNIVERSITY   (China)

^b ANHUI MEDICAL UNIVERSITY   (China)

^c SUN YAT SEN UNIVERSITY   (China)

^d UNIVERSITY OF SALFORD   (United Kingdom)

^e JIUJIANG UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

DEXAMETHASONE; HYDROCORTISONE SODIUM SUCCINATE; INDUCIBLE NITRIC OXIDE SYNTHASE; MESSENGER RNA; METHYLPREDNISOLONE; NITRIC OXIDE; NITRITE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN; CONTROLLED STUDY; CYST; GROWTH RATE; NONHUMAN; PERITONEUM MACROPHAGE; PRIORITY JOURNAL; RAT; TACHYZOITE; TOXOPLASMOSIS;

ANIMALIA; RATTUS; TOXOPLASMA GONDII;

ANIMALS; BRAIN; CELLS, CULTURED; DEXAMETHASONE; GLUCOCORTICOIDS; HYDROCORTISONE; MACROPHAGES, PERITONEAL; MALE; METHYLPREDNISOLONE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE II; RATS; RATS, INBRED F344; RATS, SPRAGUE-DAWLEY; TOXOPLASMA; TOXOPLASMOSIS, ANIMAL;

EID: 84891868703     PISSN: 09320113     EISSN: 14321955     Source Type: Journal    
DOI: 10.1007/s00436-013-3661-3     Document Type: Article

References (42)

1. Adams LB, Hibbs RR, Krahenbuhl JL (1990) Microbiostatic effect of murine-activated macrophages for Toxoplasma gondii. Role for synthesis of inorganic nitrogen oxides from L-arginine. J Immunol 144(7):2725-2729
2. Bohne W, Heesemann J, Gross U (1994) Reduced replication of Toxoplasma gondii is necessary for induction of bradyzoite-specific antigens, a possible role for nitric oxide in triggering stage conversion. Infect Immun 62(5):1761-1767
3. Cape JL, Hurst JK (2009) The role of nitrite ion in phagocyte function-perspectives and puzzles. Arch Biochem Biophys 484(2):190-196
4. Chandrasekar PH, Momin F (1997) Disseminated toxoplasmosis in marrow recipients, a report of three cases and a review of the literature. Bone Marrow Transplant 19(7):685-689
5. Chen X, Chen S, Li C, Zhu Y, Peng B (2011) Skewed T-cell subsets and enhanced macrophages phagocytosis in the spleen of patients with immune thrombocytopenia failing glucocorticoids. Int J Hematol 94(3):248-254
6. Da-Silva RC, Da-Silva AV, Langoni H (2010) Recrudescence of Toxoplasma gondii infection in chronically infected rats (Rattus norvegicus). Exp Parasitol 125(4):409-412
7. De-Medeiros BC, De-Medeiros CR, Werner B, Loddo G, Pasquini R, Bleggi-Torres LF (2001) Disseminated toxoplasmosis after bone marrow transplantation, report of 9 cases. Transpl Infect Dis 3(1):24-28
8. Derouin F, Lacroix C, Sumyuen MH, Romand S, Garin YJ (1995) Experimental models of toxoplasmosis. Pharmacological applications. Parasite 2(3):243-256
9. Dimitriu C, Bacb M, Lagreze WA, Jeble M (2008) Methylprednisolone fails to preserve retinal ganglion cells and visual function after ocular ischemia in rats. Invest Ophthalmol Vis Sci 49(11):5003-5007
10. Djurkovic-Djakvoic O, Milenkovic V (2001) Murine model of drug-induced reactivation of Toxoplasma gondii. Acta Protozool 40(6):99-106
11. Dubey JP (2011) Toxoplasma gondii of animals and humans. CRC, New York
12. El-Mahmoudy M, Matsuyama H, Borgan MA, Shimizu Y, El-Sayed MG, Minamoto N, Takewaki T (2002) Thymoquinone suppresses expression of inducible nitric oxide synthase in rat macrophages. Int Immunopharmacol 2(11):1603-1611
13. Everson GT, Trotter JF, Kugelmas M, Forman L (2003) Immunosuppression in liver transplantation. Minerva Chir 58(5):725-740
14. Freyre A, Falcón J, Mendez J, González M, Venzal JM, Morgades D (2003) Fetal Toxoplasma infection after oocyst inoculation of pregnant rats. Parasitol Res 89(5):352-353
15. Geller DA, Nussler AK, Silvio M, Lowenstein CJ, Shapiro RA, Wang SC, Simmons RL, Billiar TR (1993) Cytokines, endotoxin, and glucocorticoids regulate the expression of inducible nitric oxide synthase in hepatocytes. Proc Natl Acad Sci U S A 90(2):522-526
16. 15N] nitrate in biological fluids. Anal Biochem 126(1):131-138
17. Hayashi S, Chan CC, Gazzinelli R, Roberge FG (1996) Contribution of nitric oxide to the host parasite equilibrium in toxoplasmosis. J Immunol 156(4):1476-1481
18. Hide G, Morley EK, Hughes JM, Gerwash O, Elmahaishi MS, Thomasson D, Wright EA, Williams RH, Murphy RG, Smith JE (2009) Evidence for high levels of vertical transmission in Toxoplasma gondii. Parasitology 136(14):1877-1886
19. Kugler DG, Mittelstadt PR, Ashwell JD, Sher A, Jankovic D (2013) CD4+ T cells are trigger and target of the glucocorticoid response that prevents lethal immunopathology in toxoplasma infection. J Exp Med 210(10):1919-1927
20. Lang C, Gross U, Lüder CG (2007) Subversion of innate and adaptive immune responses by Toxoplasma gondii. Parasitol Res 100(2):191-203
21. Li Z, Zhao ZJ, Zhu XQ, Ren QS, Nie FF, Gao JM, Gao XJ, Yang TB, Zhou WL, Shen JL, Wang Y, Lu FL, Chen XG, Hide G, Ayala FJ, Lun ZR (2012) Differences in iNOS and arginase expression and activity in the macrophages of rats are responsible for the resistance against T. gondii infection. PLoS One 7(4):e35834
22. Minneci PC, Deans KJ, Banks SM, Eichacker PQ, Natanson C (2004) Meta-analysis, the effect of steroids on survival and shock during sepsis depends on the dose. Ann Intern Med 141(1):47-56
23. Montoya JG, Liesenfeld O (2004) Toxoplasmosis. Lancet 363(9425):1965-1976
24. Nishikawa Y, Xuan X, Makala L, Vielemeyer O, Joiner KA, Nagasawa H (2003) Characterisation of Toxoplasma gondii engineered to express mouse interferon-gamma. Int J Parasitol 33(13):1525-1535
25. Nishikawa Y, Kawase O, Vielemeyer O, Suzuki H, Joiner KA, Xuan X, Nagasawa H (2007) Toxoplasma gondii infection induces apoptosis in noninfected macrophages, role of nitric oxide and other soluble factors. Parasite Immunol 29(7):375-385
26. Rady MY, Johnson DJ, Patel B, Larson J, Helmers R (2006) Corticosteroids influence the mortality and morbidity of acute critical illness. Crit Care 10(4):R 101
27. Sathasivam S (2008) Steroids and immunosuppressant drugs in myasthenia gravis. Nat Clin Pract Neurol 4(6):317-327
28. Scharton-Kersten TM, Yap G, Magram J, Sher A (1997) Inducible nitric oxide is essential for host control of persistent but not acute infection with the intracellular pathogen Toxoplasma gondii. J Exp Med 185(7):1261-1273
29. Seabra SH, Da-Souza W, Da-Matta RA (2002) Toxoplasma gondii partially inhibits nitric oxide production of activated murine macrophages. Exp Parasitol 100(1):62-70
30. Severin VI, Soliman H, El-Matbouli M (2010) Expression of immune-regulatory genes, arginase-2 and inducible nitric oxide synthase (iNOS), in two rainbow trout (Oncorhynchus mykiss) strains following exposure to Myxobolus cerebralis. Parasitol Res 106(2):325-334
31. Sibley LD (1993) Interactions between Toxoplasma gondii and its mammalian host cells. Semin Cell Biol 4(5):335-344
32. Silva MT (2010) When two is better than one, macrophages and neutrophils work in concert in innate immunity as complementary and cooperative partners of a myeloid phagocyte system. J Leukoc Biol 87(1):93-106
33. Skariah S, McIntyre MK, Mordue DG (2010) Toxoplasma gondii: determinants of tachyzoite to bradyzoite conversion. Parasitol Res 107(2):253-260
34. Sternberg EM (2006) Neural regulation of innate immunity, a coordinated non-specific host response to pathogens. Nat Rev Immunol 6(4):318-328
35. Sumyuen MH, Garin YJ, Derouin F (1996) Effect of immunosuppressive drug regimens on acute and chronic murine toxoplasmosis. Parasitol Res 82(8):681-686
36. Suzuki Y, Orellana MA, Schreiber RD, Remington JS (1988) Interferon gamma, the major mediator of resistance against Toxoplasma gondii. Science 240(4851):516-518
37. Tarpataki N (2006) Recent developments in canine atopic dermatitis, a review. Acta Vet Hung 54(4):473-484
38. Thomasson D, Wright EA, Hughes JM, Dodd NS, Cox AP, Boyce K, Gerwash O, Abushahma M, Lun ZR, Murphy RG, Rogan MT, Hide G (2011) Prevalence and coinfection of Toxoplasma gondii and Neospora caninum in Apodemus sylvaticus in an area relatively free of cats. Parasitology 138(9):1117-1123
39. Tsianakas A, Varga G, Barczyk K, Bode G, Nippe N, Kran N, Roth J, Luger TA, Ehrchen J, Sunderkoetter C (2012) Induction of an anti-inflammatory human monocyte subtype is a unique property of glucocorticoids, but can be modified by IL-6 and IL-10. Immunobiology 217(3):329-335
40. Xiang XD, Zhou HY, Chen P (2000) Effects of nitroglycerin and dexamethasone on nitric oxide and endothelin derived from alveolar macrophages in patients with mild and middle asthma. Hunan Yi Ke Da Xue Xue Bao 25(4):363-366
41. Zhao YL, Ferguson DJ, Wilson DC, Howard JC, Sibley LD, Yap GS (2009) Virulent Toxoplasma gondii evade immunity-related GTPase-mediated parasite vacuole disruption within primed macrophages. J Immunol 182(6):3775-3781
42. Zhao ZJ, Zhang J, Wei J, Li Z, Wang T, Yi SQ, Shen JL, Yang TB, Hide G, Lun ZR (2013) Lower expression of inducible nitric oxide synthase and higher expression of arginase in rat alveolar macrophages are linked to their susceptibility to Toxoplasma gondii infection. PLoS One 8(5):e63650